Literature DB >> 23709005

The efficacy and safety of chitosan dextran gel in a burr hole neurosurgical sheep model.

Sukanya Rajiv1, Marguerite Harding, Ahmed Bassiouni, Camille Jardeleza, Amanda Drilling, Craig James, Thanh Ha, Steve Moratti, Simon Robinson, Peter-John Wormald.   

Abstract

BACKGROUND: Achieving and maintaining haemostasis is of paramount importance in neurosurgery. Chitosan has been shown in both animal and human models to be significantly effective in haemostasis as well as in reducing adhesion formation.
OBJECTIVES: To evaluate the haemostatic potential and to study histopathological changes caused by novel chitosan dextran gel in a neurosurgical sheep model.
METHOD: Ten sheep underwent neurosurgical burr hole procedure. Bleeding control was tested at the level of bone, dura and brain separately with both chitosan gel and Gelfoam paste on separate burr holes. Baseline bleeding was measured at the time of injury using the Boezaart scale, and then every 2 min after the application of each agent until complete haemostasis or 10 min, whichever was earlier. Safety was assessed through MRI scans and histopathological analysis.
RESULTS: Mixed modeling showed no statistical difference in time to haemostasis between chitosan gel and Gelfoam paste (means of log-normalized areas under the curve were 1.3688 and 1.3196 respectively) for each burr hole (p = 0.7768). Logistic regression modeling showed that Chitosan significantly decreased the incidence of bleeding beyond the first time point measured after application of the treatment when compared to Gelfoam (OR = 2.7, p = 0.04). Average edema volume (cm(3)) on post-operative MRI was 0.97 for Gelfoam and 1.11 for (p = 0.49) while average histology scores were 2.5 for Gelfoam versus 3.3 for chitosan (p = 0.32).
CONCLUSION: Chitosan dextran gel is an effective haemostatic agent to control bleeding in brain tissue. It is safe and nontoxic to neural tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23709005     DOI: 10.1007/s00701-013-1767-0

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

Review 1.  Efficacy of chitosan dressing on endoscopic sinus surgery: a systematic review and meta-analysis.

Authors:  Jing-Chun Zhou; Jing-Jing Zhang; Wei Zhang; Zhao-Yang Ke; Bo Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-29       Impact factor: 2.503

2.  Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy.

Authors:  Maggie Chan; Heather J L Brooks; Stephen C Moratti; Lyall R Hanton; Jaydee D Cabral
Journal:  Int J Mol Sci       Date:  2015-06-16       Impact factor: 5.923

3.  Immunological Risk Assessment of Xenogeneic Dural Patch by Comparing with Raw Material via GTKO Mice.

Authors:  Yufeng Mu; Anliang Shao; Li Shi; Bin Du; Yongjie Zhang; Jie Luo; Liming Xu; Shuxin Qu
Journal:  Biomed Res Int       Date:  2022-01-17       Impact factor: 3.411

4.  Efficacy and Safety of Novel Beta-Chitin Patches as Haemostat in Rat Vascular and Neurosurgical Model.

Authors:  Ahad Sabab; Rajan Sundaresan Vediappan; John Finnie; C John McAdam; Alistair Jukes; Sarah Vreugde; Peter-John Wormald
Journal:  Front Surg       Date:  2022-04-08

5.  Effect of a Chitosan Gel on Hemostasis and Prevention of Adhesion After Endoscopic Sinus Surgery.

Authors:  Young-Jun Chung; Se-Young An; Je-Yeob Yeon; Woo Sub Shim; Ji-Hun Mo
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-04-19       Impact factor: 3.372

6.  Functional Analysis of Injectable Substance Treatment on Surgically Injured Rabbit Vocal Folds.

Authors:  Sarah Bouhabel; Scott Park; Ksenia Kolosova; Neda Latifi; Karen Kost; Nicole Y K Li-Jessen; Luc Mongeau
Journal:  J Voice       Date:  2021-08-02       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.